Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 011878
Company: NOVARTIS
Company: NOVARTIS
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| SERPASIL-ESIDRIX #1 | HYDROCHLOROTHIAZIDE; RESERPINE | 25MG;0.1MG | TABLET;ORAL | Discontinued | None | No | No |
| SERPASIL-ESIDRIX #2 | HYDROCHLOROTHIAZIDE; RESERPINE | 50MG;0.1MG | TABLET;ORAL | Discontinued | None | No | No |